BIOGEN <BIIB.O>: JP MORGAN RAISES TO OVERWEIGHT FROM NEUTRAL; RAISES TARGET PRICE TO $300 FROM $210

Reuters2026/10/12 04:21

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

FLOWSERVE CORPORATION <FLS.N>: MIZUHO CUTS TARGET PRICE TO $85 FROM $91

Reuters•2026/10/15 10:38

Thailand crypto ETFs may see slow start despite new rules: CoinShares

Cointelegraph•2026/10/15 09:45

NASDAQ TRADE HALT CONTINUES <MCTA.O> REASON NOT AVAILABLE AT 03:58 AM

Reuters•2026/10/15 07:58

Warburg Pincus CEO Says Investors See Public Markets as One Big Bet

BeInCrypto•2026/10/15 03:12